Steven D. Culler, PhD

Articles by Steven D. Culler, PhD

Impact of Electronic Information Exchange on Repeat Imaging During 30-Day Readmissions Among Medicare Beneficiaries

BySara D. Turbow, MD, MPH,Steven D. Culler, PhD,E. Camille Vaughan, MD, MS,Kimberly J. Rask, MD, PhD,Molly M. Perkins, PhD, MA,Carolyn K. Clevenger, DNP, RN, GNP-BC, AGPCNP-BC,Mohammed K. Ali, MD, MBA, MSc

February 8th 2024

This analysis of Medicare data examines the relationships between fragmented readmission, health information exchange, and repeat imaging in older adults with and without Alzheimer disease.

Hospital Resource Consumption in Patients with Diabetes and Multivessel Coronary Disease Undergoing Revascularization

BySteven D. Culler, PhD,William S. Weintraub, MD,Leslee J. Shaw, PhD,Edmund R. Becker, PhD

February 1st 2000

The Effect of Primary Care Gatekeepers on the Management of Patients with Chest Pain

ByKimberly J. Rask, MD, PhD,Christi Deaton, RN, PhD,Steven D. Culler, PhD,Susan A. Kohler, RN, MPH,Douglas C. Morris, MD,William A. Alexander, MD

October 1st 1999

The Changing Healthcare Market and How It Has Influenced the Treatment of Cardiovascular Disease - Part I

ByEdmund R. Becker, PhD,Douglas C. Morris, MD,Steven D. Culler, PhD,Patrick D. Mauldin, PhD,Leslee J. Shaw, PhD,J. David Talley, MD,Will

September 1st 1999

The Changing Healthcare Market: Outlook for the Future of Cardiovascular Disease Treatment - Part II

ByEdmund R. Becker, PhD,Douglas C. Morris, MD,Steven D. Culler, PhD,Patrick D. Mauldin, PhD,Leslee J. Shaw, PhD,J. David Talley, MD,Will

September 1st 1999

Latest Updated Articles

Impact of Electronic Information Exchange on Repeat Imaging During 30-Day Readmissions Among Medicare Beneficiaries
February 8th 2024
Hospital Resource Consumption in Patients with Diabetes and Multivessel Coronary Disease Undergoing Revascularization
February 1st 2000
The Changing Healthcare Market and How It Has Influenced the Treatment of Cardiovascular Disease - Part I
September 1st 1999
The Changing Healthcare Market: Outlook for the Future of Cardiovascular Disease Treatment - Part II
September 1st 1999
The Effect of Primary Care Gatekeepers on the Management of Patients with Chest Pain
October 1st 1999

Steven D. Culler, PhD

Articles by Steven D. Culler, PhD

Impact of Electronic Information Exchange on Repeat Imaging During 30-Day Readmissions Among Medicare Beneficiaries

Hospital Resource Consumption in Patients with Diabetes and Multivessel Coronary Disease Undergoing Revascularization

The Effect of Primary Care Gatekeepers on the Management of Patients with Chest Pain

The Changing Healthcare Market and How It Has Influenced the Treatment of Cardiovascular Disease - Part I

The Changing Healthcare Market: Outlook for the Future of Cardiovascular Disease Treatment - Part II

Latest Updated Articles

Trending on AJMC

Flatiron’s AI-Driven Telescope Makes Data Access More User-Friendly

Social Factors May Match, Outpace Genetic Risk in Disease Prediction

First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention

Long-Term, Consistent Resistance Training Linked to Substantially Lower Type 2 Diabetes Risk

Mixed Phase 3 Results for IB6-Targeting ADC Raise Questions on Optimal Use in NSCLC

Access, Affordability, & Accountability: A New Era in Oncology Reimbursement

Steven D. Culler, PhD

Articles by Steven D. Culler, PhD

Impact of Electronic Information Exchange on Repeat Imaging During 30-Day Readmissions Among Medicare Beneficiaries

Hospital Resource Consumption in Patients with Diabetes and Multivessel Coronary Disease Undergoing Revascularization

The Effect of Primary Care Gatekeepers on the Management of Patients with Chest Pain

The Changing Healthcare Market and How It Has Influenced the Treatment of Cardiovascular Disease - Part I

The Changing Healthcare Market: Outlook for the Future of Cardiovascular Disease Treatment - Part II

Latest Updated Articles

Trending on AJMC

Flatiron’s AI-Driven Telescope Makes Data Access More User-Friendly

Social Factors May Match, Outpace Genetic Risk in Disease Prediction

First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention

Long-Term, Consistent Resistance Training Linked to Substantially Lower Type 2 Diabetes Risk

Mixed Phase 3 Results for IB6-Targeting ADC Raise Questions on Optimal Use in NSCLC